The Perfect Summary Podcast
Every summary, narrated: the GIST of great conversations and books in minutes, so you can decide if you want the REST.
FiltersHuberman LabConsciousnessClear
Pick as many as you like: any of them matches within a group.
Johns Hopkins researcher Dr. Matthew Johnson explains how psilocybin, MDMA and other psychedelics are studied as treatments, and what the real risks are.
Sam Harris explains why meditation's real prize is seeing through the self, how it differs from psychedelics, and why he quit Twitter.
Movement teacher Ido Portal and Andrew Huberman explore play versus discipline, exposing will, transition states and refining body awareness.
Michael Pollan and Andrew Huberman on what plants, microbes, and psychedelics reveal about consciousness, the self, food politics, and caffeine.
Allan Schore explains how right brain to right brain bonds in infancy shape attachment, emotion regulation and every adult relationship.
Lisa Feldman Barrett explains why emotions are the brain's predictions, why faces don't reveal feelings, and how the body budget shapes mood.
Neuroscientist David Linden explains what makes each of us unique, how mind and body talk, and what terminal cancer taught him about gratitude.
Andrew Huberman explains how psilocybin acts on serotonin 2A receptors, what makes sessions therapeutic, trial results for depression, and the risks.
Robin Carhart-Harris explains how psilocybin therapy works, what it changes in the brain, why microdosing disappoints and where legalization stands.
Sam Harris explains why meditation's real promise is seeing through the illusion of the self, plus free will, psychedelics and quitting Twitter.
Stanford's Nolan Williams explains how TMS and psychedelic therapies recalibrate mood circuits, and why they belong under medical care.
Charles Zuker explains how the brain builds taste, why the tongue map is a myth, and why gut signals, not the tongue, drive sugar cravings.
Stanford psychiatrist David Spiegel explains what clinical hypnosis does in the brain and how it helps with pain, stress, sleep, phobias and trauma.
Dr. Matthew Johnson explains how psychedelic therapy works in clinical trials, why it helps depression and addiction, and its real risks and limits.
Psychiatrist and optogenetics pioneer Karl Deisseroth on why psychiatry relies on words, light-controlled neurons, and how psychedelics and MDMA may help.